AtriCure (ATRC) Insider Trading & Ownership $37.65 -0.55 (-1.44%) (As of 10:33 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AtriCure (NASDAQ:ATRC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.20%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$111,250.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$589,176.76 Get ATRC Insider Trade Alerts Want to know when executives and insiders are buying or selling AtriCure stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ATRC Insider Buying and Selling by Quarter Ad Brownstone ResearchBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.I believe we are about to do it again with this new AI project called Stargate AtriCure Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/15/2024Maggie YuenDirectorSell3,500$24.07$84,245.00 7/19/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$24.17$1,001 - $15,0006/18/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$21.20$1,001 - $15,0005/30/2024Salvatore PriviteraInsiderBuy5,000$22.25$111,250.00 5/1/2024Justin J NozneskyInsiderSell1,500$24.09$36,135.00 4/1/2024Justin J NozneskyInsiderSell1,500$30.39$45,585.00 3/18/2024Karl S DahlquistInsiderSell1,885$32.16$60,621.60 3/12/2024Justin J NozneskyInsiderSell1,500$36.72$55,080.00 3/5/2024Karl S DahlquistInsiderSell8,231$37.36$307,510.16 (Data available from 1/1/2013 forward) ATRC Insider Trading Activity - Frequently Asked Questions Who is on AtriCure's Insider Roster? The list of insiders at AtriCure includes Justin J Noznesky, Karen Prange, Karl S Dahlquist, Maggie Yuen, Salvatore Privitera, Tonya Austin, and Vinayak Doraiswamy. Learn more on insiders at ATRC. What percentage of AtriCure stock is owned by insiders? 3.20% of AtriCure stock is owned by insiders. Learn more on ATRC's insider holdings. Which AtriCure insiders have been buying company stock? The following insider purchased ATRC shares in the last 24 months: Salvatore Privitera ($111,250.00). How much insider buying is happening at AtriCure? Insiders have purchased a total of 5,000 ATRC shares in the last 24 months for a total of $111,250.00 bought. Which AtriCure insiders have been selling company stock? The following insiders have sold ATRC shares in the last 24 months: Justin J Noznesky ($136,800.00), Karen Prange ($34,145.57), Karl S Dahlquist ($673,053.59), and Maggie Yuen ($287,128.52). How much insider selling is happening at AtriCure? Insiders have sold a total of 29,229 AtriCure shares in the last 24 months for a total of $1,131,127.68 sold. Which members of congress are trading AtriCure? Josh Gottheimer (D-NJ) has bought shares of AtriCure in the last year totaling $8,000. Josh Gottheimer (D-NJ) has sold shares totaling $8,000. AtriCure Key ExecutivesMr. Michael H. Carrel (Age 53)CEO, President & Director Compensation: $2.01MMs. Angela L. Wirick CPA (Age 46)Chief Financial Officer Compensation: $841.54kMr. Douglas J. Seith (Age 58)Chief Operating Officer Compensation: $1.2MMr. Salvatore Privitera J.D. (Age 57)Chief Technical Officer Compensation: $758.8k1 recent tradesMr. Karl S. Dahlquist CCEP (Age 53)J.D., Chief Legal Officer Compensation: $762.39kDr. Vinayak Doraiswamy Ph.D. (Age 52)Chief Scientific Officer Compensation: $777.66kValerie Storch-WillhausVice President of Corporate Marketing & CommunicationsMr. Justin J. Noznesky (Age 46)Chief Marketing & Strategy Officer Compensation: $644.73kMs. Deborah Yount (Age 58)Chief Human Resources Officer Compensation: $498.36k More Insider Trading Tools from MarketBeat Related Companies SILK Insider Trading ATRI Insider Trading LUNG Insider Trading INO Insider Trading ITGR Insider Trading IART Insider Trading ATEC Insider Trading OFIX Insider Trading SRDX Insider Trading ANGO Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Here’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock This page (NASDAQ:ATRC) was last updated on 11/12/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | SponsoredWith a $2B neighbor nearby, this underfollowed lithium explorer could have the next big strike!This Lithium Company Scoops Up the Largest Continuous Land Package in Brazil’s Lithium Boom Positioning the Co...Huge Alerts | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AtriCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.